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Abstract
Background: Graphical symbols on in vitro diagnostics (IVD symbols) replace the need for text in different
languages and are used on malaria rapid diagnostic tests (RDTs) marketed worldwide. The present study assessed
the comprehension of IVD symbols labelled on malaria RDT kits among laboratory staff in four different countries.
Methods: Participants (n = 293) in Belgium (n = 96), the Democratic Republic of the Congo (DRC, n = 87),
Cambodia (n = 59) and Cuba (n = 51) were presented with an anonymous questionnaire with IVD symbols
extracted from ISO 15223 and EN 980 presented as stand-alone symbols (n = 18) and in context (affixed on RDT
packages, n = 16). Responses were open-ended and scored for correctness by local professionals.
Results: Presented as stand-alone, three and five IVD symbols were correctly scored for comprehension by 67%
and 50% of participants; when contextually presented, five and seven symbols reached the 67% and 50% correct
score respectively. ‘Batch code’ scored best (correctly scored by 71.3% of participants when presented as stand-
alone), ‘Authorized representative in the European Community’ scored worst (1.4% correct). Another six IVD
symbols were scored correctly by less than 10% of participants: ‘Do not reuse’, ‘In vitro diagnostic medical device’,
‘Sufficient for’, ‘Date of manufacture’, ‘Authorised representative in EC’, and ‘Do not use if package is damaged’.
Participants in Belgium and Cuba both scored six symbols above the 67% criterion, participants from DRC and
Cambodia scored only two and one symbols above this criterion. Low correct scores were observed for safety-
related IVD symbols, such as for ‘Biological Risk’ (42.7%) and ‘Do not reuse’ (10.9%).
Conclusion: Comprehension of IVD symbols on RDTs among laboratory staff in four international settings was
unsatisfactory. Administrative and outreach procedures should be undertaken to assure their acquaintance by end-
users.
Keywords: Graphical symbols, in vitro diagnostics, ISO 15223, malaria rapid diagnostic tests
Background
Graphical symbols on in vitro diagnostics
To achieve international market compliance, medical
devices and in vitro d i a g n o s t i c s( I V D s )m u s td i s p l a y
technical and safety information on their packaging. For
that purpose, graphical symbols as published in the
International Organization of Standardization (ISO
15223) and the European Norm EN 980 may be used.
Both the European Union and the US Food and Drug
Administration (through directive 98/79/EC and FDR
21 809.10 and 21 respectively) recommend the use of
graphical symbols on medical devices and in vitro diag-
nostic devices, further referred to as ‘IVD symbols’
(Figure 1). Apart from obviating the need for supplying
information in different languages, graphical symbols
have advantages over full text such as high visual impact
and noticeability [1].
In a previous study, IVD symbols were noted on the
labels of all 40 boxes of malaria rapid diagnostic kits
(RDTs) [2]. Although it might be assumed that laboratory
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ing of IVD symbols, this assumption has to be confir-
med. The present study was done as part of a network
programme on laboratory quality management: as a
preparation of dedicated training on IVD symbols, the
comprehension of diagnostic symbols figuring on RDT
kits was assessed among laboratory staff in four different
settings.
 
ISO 15223-1:2007: Medical devices - Symbols to be used with medical device labels, 
labelling and information to be supplied - Part 1: General requirements (International level).  
This part of ISO 15223 identifies requirements for the development and use of symbols that may be 
used to convey information on the safe and effective use of medical devices. 
 
ISO 3864-1:2002: Graphical symbols - Safety colours and safety signs - Part 1: Design 
principles for safety signs in workplaces and public areas. 
This part of ISO 3864 establishes the safety identification colors and design principles for safety signs 
to be used in workplaces and in public areas for the purpose of accident prevention, fire protection, 
health hazard information and emergency evacuation.  
 
EN 980:2008: Graphical Symbols for use in the labelling of medical devices.  
This European Norm (EN) has been prepared to describe the legislative regulations within the 
European Union (EU) for the use of symbols in medical device labelling, thereby reducing the need for 
multiple translations of words into national languages.  
 
EU DIRECTIVE 98/79EC: In-vitro Diagnostic Medical Device Directive of the European 
Community (EC), published in 1998.  
 This Directive recognizes the option of using harmonized symbols as a substitute for the different 
ODQJXDJHVXVHGLQWKH(8³$Q\V\PERODQGLGHQWLILFDWLRQFRORXUXVHGPXVWFRQIRUPWRWKHKDUPRQLVHG
standards. In areas for which no standards exist, the symbols and colour used must be described in the 
GRFXPHQWDWLRQVXSSOLHGZLWKWKHGHYLFH´ 
 
FDA 2004, 21 CFR 809.10 and 21 CFR parts 610 and 660: This document of the United 
States of America Food and Drug Administration provides Guidance on the use of selected symbols in 
place of text to convey some of the information required for in vitro diagnostic devices (IVDs) 
intended for professional use. 
FDA recognizes 25 symbols for IVD devices for professional use from the following two international 
consensus standards: ISO 15223 and EN 980. FDA recommends that a glossary of terms accompany 
each IVD to GHILQHDOORIWKHV\PEROVXVHGRQWKDWGHYLFH¶VODEHOVDQGRUODEHOOLQJ7KLVJORVVDU\PD\
also contain other symbols identified by FDA in its recognition of ISO 15223 and EN 980. 
 
Globally Harmonized System of Classification and Labeling of Chemicals  (GHS):  
GHS is an internationally agreed upon system set to replace the various different classification and 
labeling standards used in different countries. It is a common and consistent approach to defining and 
classifying hazards, and communicating hazard information on labels and safety data sheets (SDS).  
Figure 1 International standard regulations that provide guidelines on the use of symbols on IVDs and medical devices.
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Study sites and ethical considerations
The survey was conducted at institutions in four different
countries: (i) Institute of Tropical Medicine (ITM),
Antwerp, Belgium, (ii) Institut National de Recherche Bio-
médicale (INRB), Kinshasa, Democratic Republic of the
Congo (DRC), (iii) Sihanouk Hospital Centre of Hope
(SHCH), Phnom Penh, Cambodia, (iv) Institute of Tropi-
cal Medicine Pedro Kouri (IPK), Havana, Cuba. The study
consisted of an on-site survey during which an anonymous
questionnaire was presented. The study was approved by
the Institutional Review Board (IRB) of ITM, Antwerp,
and by the Ethical Committee of Antwerp University,
Belgium.
Period, participants and recruitment
The survey was conducted between April 2009 and
September 2009. The targeted study participants were
laboratory health care workers (HCW) who worked regu-
larly with IVDs in diagnostic laboratories: doctors, phar-
macists, biologists, chemists, laboratory technicians and
students in biomedical science and medicine. Participants
were addressed by the local collaborator at each study site
during breaks in training sessions or meetings on unre-
lated topics.
Questionnaire
The questionnaire was available in four languages
(Dutch, English, French and Spanish), which had been
back-translated by local collaborators. It was preceded by
an information letter explaining the purpose of the study
and asking for consent. Next, written instructions were
given. Eighteen IVD symbols were included: all were IVD
symbols used on RDT kits and extracted from ISO 15223
and EN 980 [3,4]; they were presented in black-and-
white prints (Figure 2). The questionnaire consisted of
two parts: the first part presented the IVD symbols as
stand-alone symbols and the second part presented 16 of
them in context, i.e. as displayed on a colour photograph
of a malaria RDT kit package. The questionnaire was
open-ended: participants were asked to write down in
their own words the presumed meaning, according to
ISO 9186 [1,3]. Questionnaires were collected immedi-
ately after completion.
Sample sizes, end points, data registration and analysis
In line with other studies on symbol comprehension, a
target of 50 to 100 participants for each setting was set
[1,5]. Answers were compared to the correct meaning of
each symbol as described in ISO 15223 and EN 980 and
interpreted as correct or incorrect. A correct answer
meant that the meaning was identical or fully consistent
with the reference. Blanks and answers like ‘I don’t know’
were assigned to the category ‘incorrect’. Interpretations
were done in consensus with the local collaborator at
each site. For definition of an acceptable score, the criter-
ion used by Liu and co-workers evaluating IVD symbols
in intensive care units was used, i.e. ≥ 67% of surveyed
participants answering correctly based on the ISO 3864
version 1984 [1,6]. In addition, a second, more permissive
threshold of 50%, correct score was used, in line with
Kassam and co-workers assessing pictographic instruc-
tions for medications [7]. Data were collected on A4
paper folders and subsequently labelled with a single
identifier. They were recorded in a Microsoft Excel
spreadsheet. Proportions were tested with the Pearson’s
chi-square (c
2) test. A p-value < 0.05 was considered to
be significant.
Results
Participants
A total of 293 HCW from four settings participated: Bel-
gium: n = 96, DRC: n = 87, Cambodia: n = 59 and Cuba: n
= 51. The male-to-female ratio was 1:0.74. Of the 293 par-
ticipants, a Bachelor’s degree was held by 49.1%, 35.5%
held Master degrees; the remaining participants were stu-
dents. Professional experience in years was highest among
the participants from Cuba (median 18.5 years, range 2-
26), followed by participants from Belgium (median 9.5
years, range 0.5-37), Cambodia (median 8.0 years, range
0.5-25) and DRC (median 4.5 years, range 0-35).
Comprehension of IVD symbols as stand-alone symbols
For all 293 participants combined, three and five out of
18 symbols reached the 67% and 50% scores (Figure 2).
‘Batch code’ scored best (correctly scored by 71.3% of
participants) and the lowest score was noted for ‘Author-
ized representative in EC’ (1.4%). None of the IVD sym-
bols reached the 67% score in all four settings but two
reached the 50% score (‘Temperature limitation’ and
‘Keep dry’). Participants of Belgium and Cuba both
scored six symbols above the 67% ISO 3864 criterion,
participants from DRC and Cambodia scored two and
one symbol above this criterion respectively. The most
striking difference between the settings was noted for the
‘Biological risk’ symbol, which was scored correctly by
94.1% and 8.0% of participants from Cuba and DRC
respectively (p < 0.001). Another six IVD symbols were
scored correctly by less than 10% of participants in all
four settings: ‘Do not reuse’, ‘In vitro diagnostic medical
device’, ‘Sufficient for’, ‘Date of manufacture’, ‘Authorised
representative in EC’,a n d‘Do not use if package is
damaged’.
Comprehension of symbols when presented in context
Sixteen symbols among those shown in the first part
(stand-alone symbols) were presented in context by
showing pictures of malaria RDT packages (Figures 3, 4
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in context were correctly identified significantly more
frequently compared to their scores as stand-alone sym-
bols (Figure 6): ‘Catalogue number’, ‘Batch code’,
‘Temperature limitation’, ‘Use by’, ‘Manufacturer’, ‘Date
of manufacture’ and ‘Sufficient for’, with overall correct
scores of respectively 78.5%, 76.1%, 70.0%, 54.3%, 44.7%
and 20.5%. No increase at all was noted for the low-
Symbols  Meaning 
 
Belgium 
(n = 96) 
 
DRC 
(n = 87) 
 
Cambodia 
(n = 59) 
 
Cuba 
(n = 51) 
 
Total 
(n = 293) 
         
  Catalogue number 
 
77.1 
 
80.5 
 
40.7 
 
64.7 
 
68.6 
  Batch code 
 
88.5 
 
64.4 
 
47.5 
 
78.4 
 
71.3 
 
Consult 
instructions for use 
 
50.0 
 
14.9 
 
13.6 
 
17.6 
 
26.6 
  Do not reuse 
 
4.2 
 
12.6 
 
22.0 
 
9.8 
 
11.3 
 
In vitro diagnostic 
medical device  
 
13.5 
 
9.2 
 
10.2 
 
35.3 
 
15.4 
  Manufacturer 
 
21.9 
 
18.4 
 
37.3 
 
31.4 
 
25.6 
  Sufficient for 
 
2.1 
 
6.9 
 
6.8 
 
27.5 
 
8.9 
 
Use by 
 
37.5 
 
44.8 
 
45.8 
 
62.7 
 
45.7 
 
Temperature 
limitation 
 
75.0 
 
52.9 
 
55.9 
 
74.5 
 
64.5 
  Non-sterile 
 
64.6 
 
36.8 
 
23.7 
 
62.7 
 
47.8 
 
Keep away from 
sunlight 
 
45.8 
 
46.0 
 
42.4 
 
72.5 
 
49.8 
 
Keep dry 
 
67.7 
 
56.3 
 
76.3 
 
88.2 
 
69.6 
 
Biological risk 
 
62.5 
 
8.0 
 
35.6 
 
94.1 
 
46.4 
 
Date of 
manufacture 
 
2.1 
 
11.5 
 
10.2 
 
29.4 
 
11.3 
 
Authorised 
representative in 
EC 
 
0.0 
 
0.0 
 
3.4 
 
3.9 
 
1.4 
 
Do not use if 
package is 
damaged 
 
 
37.5 
 
40.2 
 
25.4 
 
56.9 
 
39.2 
 
Sterilized using 
steam or dry heat 
 
 
8.3 
 
0.0 
 
8.5 
 
3.9 
 
5.1 
  Caution 
   
64.6 
 
77.0 
 
45.8 
 
41.2 
 
60.4 
Figure 2 Graphical symbols used in this survey, their meaning and percentage of correct answers by participants from the different
settings, when assessed as stand-alone symbols.
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medical device’, ‘Do not reuse’ and ‘Authorised repre-
sentative in EC’. There were no differences in improved
identification between the four study settings. Overall,
five and seven diagnostic symbols reached the 67% ISO
3864 and the 50% criteria respectively.
Discussion
The use of graphical symbols on IVDs is encouraged by
EU and FDA
To be released on international markets, RDTs like other
IVDs are required to display product information on
their packaging, including information about manufac-
turer, storage temperature, manufacture and expiration
dates and several instructions for use [2]. To avoid the
need for translation of this information in different lan-
guages and to comply with space limitations, manufac-
turers use IVD symbols that convey the required
information [8]. Both EU and FDA regulations recognize
and authorize the use of these IVD symbols. In the EU,
the original motivation for stimulating the use of graphic
symbols was to obviate the need for translating the infor-
mation in all national languages of the community, but
other advantages such as noticeability, standardization
Figure 3 A package of malaria RDT Palutop
® +4. This picture was used to present 10 IVD symbols in context.
Figure 4 A package of malaria RDT First Response
® malaria antigen test” This picture was used to present four additional IVD
symbols in context (’Non-sterile’, ‘Keep away from sunlight’, ‘Keep dry’ and ‘Biological risk’).
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[3,9].
Limitations of the present study
The present study has some limitations. For instance,
although they were instructed not to do so, participants
filling out the second part (symbols in context) were the-
oretically able to go back to the first part (stand-alone
symbols) and make corrections. However, the significant
differences in scores between both categories indicated
that this had not occurred in practice. Further, despite
complying with the professional languages of the target
audience, writing in English or French proved difficult
for some participants in Cambodia and DRC, which in
turn led to occasional difficulty in scoring responses. The
option of multiple-choice questions would have avoided
possible errors in interpretation. However, the so-called
open-ended comprehension method is recommended for
surveys of symbol comprehension, such as for IVD and
safety symbols or icons in consumer medical information
[1,10-12], and multiple-choice questions would have suf-
fered from interferences of recall and suggestion [13]. In
addition, reliability in the present study was assured by
interpreting the answers in collaboration with a local col-
laborator who corrected for linguistic factors. Finally,
participants’ familiarity with RDTs was not registered,
although the majority of them had little experience.
Among the four settings, malaria is only endemic in
DRC, but malaria RDTs were not yet released at the time
of the survey. Nevertheless, all participants were actual
end-users of IVDs (such as HIV RDTs) and hence sup-
posed to be exposed to IVD symbols. Finally, it should be
noted that the present study did not assess the factual
consequences of non-comprehension of symbols in terms
of practical handling and diagnostic accuracy.
The comprehension of IVD symbols on RDTs is poor
The present study showed that laboratory staff in different
international settings scored poorly at comprehension of
IVD symbols displayed on RDTs. This is in contrast to the
general perception of regulatory authorities: FDA refers to
internal validation processes to claim understanding of the
symbols by laboratory users of various educational back-
grounds, providing acquaintance through information leaf-
lets and training. Likewise, EN 980:2008 describes the IVD
symbols as self-evident to healthcare professionals with no
need for further explanation (with the exception of the
symbol ‘Do not use when package is damaged’) [3,9]. Of
most concern are the low scores for the IVD symbols
related to safety, e.g. ‘Biological risk’, ‘Do not reuse’ and
‘Consult instructions before use’, even when presented in
context, since IVD symbols are considered an important
element in risk reduction [3]. Despite these claims, it is
clear that actual comprehension of the IVD symbols does
not reach the intended level, which suggest to review the
comprehension validation procedures.
Most graphical symbols in use in community or profes-
sional life pertain to transportation, industry or trade [14]
and few evaluations of the comprehension of graphical
symbols among end-users have been conducted, particu-
larly in non-industrialized countries. When performed,
comprehension studies focused on hazard or chemical
symbols and addressed industry, agriculture of trade
workers [5,15]. Only a single study assessed the compre-
hension of symbols among HCW in Germany and China:
among the surveyed symbols (displayed on electrical and
Figure 5 A package of malaria RDT Visitec malaria combo pan/Pf. This picture was used to present the IVD symbol ‘Date of manufacture’ in
context. NB: the symbol used for ‘Sufficient for’ is not required by EN 980: the inverted triangle should contain the ‘∑’ character and affix the
number beneath.
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of manufacture’ and ‘Do not reuse’. These two symbols
scored poorly (correct by less than 50% of participants)
both in Germany and China.
Comprehension of symbols: pictorial and abstract designs
Graphical symbols are either pictorial/iconic (i.e. pre-
senting familiar objects from daily life or alphanumeric
data) or abstract (displaying an arbitrary figure). In the
 
Symbol 
 
Stand-alone  In context  p-value* 
 
  71.3    78.5    0.046 
 
  69.6    73.0    N.S 
 
  68.6    76.1    0.042 
 
  64.5    73.7    0.016 
 
  49.8    57.3    N.S. 
 
  47.8    54.3    N.S. 
 
  46.4    42.7    N.S. 
 
  45.7    70.0    <0.001 
 
  26.6    28.7    N.S. 
    25.6    54.3    < 0.001 
 
  15.4    16.7    N.S. 
    11.3    10.9    N.S. 
    11.3    44.7    < 0.001 
 
  8.9    20.5    < 0.001 
 
  1.4    3.4    N.S. 
*N.S.: not significant  
Figure 6 Percentages of overall correct scores for each symbol when presented as stand-alone versus in context for 293 participants.
Symbols are ranked from highest to lowest score when presented as stand-alone.
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umbrella of the ‘Keep dry’ symbol, generally scored bet-
ter compared to abstract symbols, which scored lower
even when presented in context and with dates or num-
bers referring to their meaning. The symbols ‘Date of
manufacture’ and ‘Sufficient for’ did not reach the 50%
correct score. Similar findings were observed for chemi-
cal hazard symbols surveyed among agricultural and
industrial workers in Zambia: flame-like symbols were
better understood than the St Andrew’s cross [15]. On
the other hand, pictorial symbols may entail confoun-
ders: i.e. the ‘Do not reuse’ symbol was explained as ‘Do
not give to children under two years old’ by several par-
ticipants in the present survey.
Comprehension of symbols: design, acquaintance,
education and culture
Acquaintance and familiarity with graphical symbols are
other factors favouring comprehension. For instance, the
symbol ‘Biological risk’-an abstract symbol-was best
scored by the participants from Cuba, who had partici-
pated to a training in bio-safety matters shortly before
the survey. Training and education are essential tools in
the comprehension of chemical and safety symbols [16].
Likewise, the symbol ‘Consult instructions before use’
was scored best by the participants in Belgium, probably
by a familiarity with other types of consumables and
equipment marketed in the EU and affixing these
symbols.
Finally, there is a possible role for cultural and educa-
tional factors. The present study was not designed to
assess such factors and published literature provides little
information about the relationship between cultural back-
ground and symbol comprehension. In a community set-
ting in South Africa, locally designed pictograms for
medicine instructions were better comprehended than
internationally available pictograms [10], whereas a study
of medicine instructions among immigrants of non-
European descent in Canada showed that interpretation
was related to educational level and visual literacy rather
than to ethnic or demographic factors [7]. In the afore-
mentioned study of symbols in intensive care units in
Germany and China, no apparent cultural differences were
identified but professional experience was identified as a
factor influencing symbol comprehension [1].
Improving the comprehension of IVD symbols
Studies on the information transfer of consumer medical
information clearly showed the synergistic effect of pictor-
ial aids and textual instructions: displaying text together
with symbols improves attention, comprehension and
recall of the message, as is practiced on some RDT
packages (Figure 7) [10,17-20]. To increase acquaintance
with the symbols, FDA recommends that IVD
Figure 7 A package of malaria RDT Immunospec malaria Pf/Pv cassette test, using the synergistic effect to show both pictorial aids
and textual instructions.
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IVD symbols [9]: this practice was recorded in 9/42
(21.4%) RDT brands assessed for quality of labelling and
information sheets [2]. Another FDA recommendation is
to organize educational outreach efforts by training, let-
ters, posters and advertisements in professional journals
and websites [9]. Finally, for the introduction of new sym-
bols, the use of pictorial rather than abstract symbols
should be considered.
Conclusion
In conclusion, comprehension of IVD symbols on RDTs
among laboratory staff in four international settings was
unsatisfactory. Administrative and outreach procedures
should be undertaken to explain the meaning of IVD
symbols and to assure their acquaintance by end-users.
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